Your browser doesn't support javascript.
loading
A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms.
Owen, Dwight H; Benner, Brooke; Wei, Lai; Sukrithan, Vineeth; Goyal, Ashima; Zhou, Ye; Pilcher, Carly; Suffren, Sheryl-Ann; Christenson, Gwen; Curtis, Nancy; Jukich, Megan; Schwarz, Emily; Savardekar, Himanshu; Norman, Ruthann; Ferguson, Sarah; Kleiber, Barbara; Wesolowski, Robert; Carson, William E; Otterson, Gregory A; Verschraegen, Claire F; Shah, Manisha H; Konda, Bhavana.
Afiliação
  • Owen DH; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Benner B; Division of Surgical Oncology, Department of Surgery, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Wei L; Department of Biomedical Informatics and Center for Biostatistics, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Sukrithan V; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Goyal A; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Zhou Y; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Pilcher C; Clinical Trials Office, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Suffren SA; Clinical Trials Office, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Christenson G; Clinical Trials Office, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Curtis N; Clinical Trials Office, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Jukich M; Clinical Trials Office, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Schwarz E; Division of Surgical Oncology, Department of Surgery, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Savardekar H; Division of Surgical Oncology, Department of Surgery, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Norman R; Division of Surgical Oncology, Department of Surgery, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Ferguson S; Clinical Trials Office, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Kleiber B; Clinical Trials Office, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Wesolowski R; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Carson WE; Division of Surgical Oncology, Department of Surgery, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Otterson GA; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Verschraegen CF; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Shah MH; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
  • Konda B; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University - James Comprehensive Cancer Center, Columbus, Ohio.
Clin Cancer Res ; 29(4): 731-741, 2023 02 16.
Article em En | MEDLINE | ID: mdl-36255391

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos